Lin C N, Liou S S, Ko F N, Teng C M
Natural Products Research Center, Kaohsiung Medical College, Taiwan, Republic of China.
J Pharm Sci. 1992 Nov;81(11):1109-12. doi: 10.1002/jps.2600811114.
Norathyriol and its analogues, 1,3,5,6-, 3,4,5,6-, 3,4,6,7- and 2,3,6,7-tetrahydroxyxanthone, were synthesized from benzophenone precursors by Friedel-Crafts acylation and subsequent base-catalyzed cyclization to eliminate methanol. Both 3,4,6,7- and 2,3,6,7-tetrahydroxyxanthone tetraacetate showed potent anti-platelet aggregation effects on arachidonic acid-induced platelet aggregation. 3,4,6,7-Tetrahydroxyxanthone tetraacetate and 1,3,5,6-tetrahydroxyxanthone showed potent and significant anti-platelet aggregation effects on collagen-induced platelet aggregation.
诺拉替罗及其类似物,1,3,5,6-、3,4,5,6-、3,4,6,7-和2,3,6,7-四羟基呫吨酮,由二苯甲酮前体通过傅克酰基化反应以及随后的碱催化环化以消除甲醇而合成。3,4,6,7-四羟基呫吨酮四乙酸酯和2,3,6,7-四羟基呫吨酮四乙酸酯对花生四烯酸诱导的血小板聚集均显示出强效的抗血小板聚集作用。3,4,6,7-四羟基呫吨酮四乙酸酯和1,3,5,6-四羟基呫吨酮对胶原诱导的血小板聚集显示出强效且显著的抗血小板聚集作用。